Georges Moarbess

503 total citations
14 papers, 414 citations indexed

About

Georges Moarbess is a scholar working on Organic Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, Georges Moarbess has authored 14 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Georges Moarbess's work include Synthesis and Biological Evaluation (9 papers), Quinazolinone synthesis and applications (5 papers) and Cancer therapeutics and mechanisms (3 papers). Georges Moarbess is often cited by papers focused on Synthesis and Biological Evaluation (9 papers), Quinazolinone synthesis and applications (5 papers) and Cancer therapeutics and mechanisms (3 papers). Georges Moarbess collaborates with scholars based in France, Lebanon and United States. Georges Moarbess's co-authors include Pierre‐Antoine Bonnet, Carine Deleuze‐Masquéfa, Françoise Bressolle, Frédéric Pinguet, Issam Kassab, Mona Diab‐Assaf, Pierre Cuq, Sonia Khier, Jean‐François Guichou and Kamel Hadj‐Kaddour and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Georges Moarbess

14 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Georges Moarbess France 10 244 100 99 34 23 14 414
Marcin Mą̨czyński Poland 12 368 1.5× 142 1.4× 68 0.7× 50 1.5× 31 1.3× 48 512
Issam Kassab Lebanon 8 115 0.5× 77 0.8× 88 0.9× 31 0.9× 23 1.0× 18 325
Manikandan Kadirvel United Kingdom 12 89 0.4× 220 2.2× 26 0.3× 37 1.1× 22 1.0× 21 378
Stanisław Ryng Poland 12 294 1.2× 67 0.7× 71 0.7× 18 0.5× 35 1.5× 49 356
Naoyuki Asakawa Japan 13 206 0.8× 245 2.5× 22 0.2× 114 3.4× 17 0.7× 22 505
Dominea C. K. Rathwell New Zealand 10 316 1.3× 204 2.0× 108 1.1× 20 0.6× 22 1.0× 14 510
Takashi Yoshino Japan 8 187 0.8× 161 1.6× 61 0.6× 58 1.7× 15 0.7× 10 444
Fang Yuan China 10 120 0.5× 127 1.3× 48 0.5× 88 2.6× 3 0.1× 21 443
Santosh Keshipeddy United States 12 115 0.5× 117 1.2× 205 2.1× 50 1.5× 7 0.3× 23 446
Meining Wang China 10 168 0.7× 159 1.6× 16 0.2× 56 1.6× 21 0.9× 16 336

Countries citing papers authored by Georges Moarbess

Since Specialization
Citations

This map shows the geographic impact of Georges Moarbess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Moarbess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Moarbess more than expected).

Fields of papers citing papers by Georges Moarbess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georges Moarbess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Moarbess. The network helps show where Georges Moarbess may publish in the future.

Co-authorship network of co-authors of Georges Moarbess

This figure shows the co-authorship network connecting the top 25 collaborators of Georges Moarbess. A scholar is included among the top collaborators of Georges Moarbess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georges Moarbess. Georges Moarbess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Millot, Nadine, Yann Pellequer, Georges Moarbess, et al.. (2022). Size effect and mucus role on the intestinal toxicity of the E551 food additive and engineered silica nanoparticles. Nanotoxicology. 16(2). 165–182. 8 indexed citations
2.
Moarbess, Georges, et al.. (2020). Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes. European Journal of Medicinal Chemistry. 193. 112238–112238. 78 indexed citations
3.
Moarbess, Georges, Jean‐François Guichou, Pierre‐Antoine Bonnet, et al.. (2019). Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series. Journal of Medicinal Chemistry. 62(15). 7015–7031. 38 indexed citations
4.
Boutros, Maya, Georges Moarbess, Thomas Onfroy, & Franck Launay. (2018). Preparation, characterization, and hydrogenation activity of new Rh0–MCM-41 catalysts prepared from as-synthesized MCM-41 and RhCl3. Comptes Rendus Chimie. 21(5). 514–522. 6 indexed citations
5.
Deleuze‐Masquéfa, Carine, Georges Moarbess, Mona Diab‐Assaf, et al.. (2018). Methylation of imidazopyrazine, imidazoquinoxaline, and pyrazoloquinoxaline through Suzuki–Miyaura cross coupling. Chemistry of Heterocyclic Compounds. 54(2). 183–187. 4 indexed citations
6.
Moarbess, Georges, Carine Deleuze‐Masquéfa, Kamel Hadj‐Kaddour, et al.. (2017). Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors. European Journal of Medicinal Chemistry. 138. 909–919. 23 indexed citations
7.
Moarbess, Georges, et al.. (2016). New IKK inhibitors: Synthesis of new imidazo[1,2-a]quinoxaline derivatives using microwave assistance and biological evaluation as IKK inhibitors. European Journal of Medicinal Chemistry. 115. 268–274. 15 indexed citations
8.
Guichou, Jean‐François, Johanna Vappiani, Nicole Bec, et al.. (2016). New imidazoquinoxaline derivatives: Synthesis, biological evaluation on melanoma, effect on tubulin polymerization and structure–activity relationships. Bioorganic & Medicinal Chemistry. 24(11). 2433–2440. 33 indexed citations
9.
Gattacceca, Florence, Georges Moarbess, Sharon Wein, et al.. (2010). Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors. European Journal of Pharmaceutical Sciences. 42(1-2). 81–90. 3 indexed citations
10.
Khier, Sonia, Carine Deleuze‐Masquéfa, Georges Moarbess, et al.. (2009). Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. European Journal of Pharmaceutical Sciences. 39(1-3). 23–29. 22 indexed citations
11.
Deleuze‐Masquéfa, Carine, Georges Moarbess, Sonia Khier, et al.. (2009). New imidazo[1,2-a]quinoxaline derivatives: Synthesis and in vitro activity against human melanoma. European Journal of Medicinal Chemistry. 44(9). 3406–3411. 37 indexed citations
12.
Khier, Sonia, Georges Moarbess, Carine Deleuze‐Masquéfa, et al.. (2009). Quantitation of imidazo[1,2‐a]quinoxaline derivatives in human and rat plasma using LC/ESI‐MS. Journal of Separation Science. 32(9). 1363–1373. 9 indexed citations
13.
Moarbess, Georges, et al.. (2008). In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Bioorganic & Medicinal Chemistry. 16(13). 6601–6610. 106 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcin Mą̨czyński Breakdown of academic impact, for papers by Issam Kassab Breakdown of academic impact, for papers by Manikandan Kadirvel Breakdown of academic impact, for papers by Stanisław Ryng Breakdown of academic impact, for papers by Naoyuki Asakawa Breakdown of academic impact, for papers by Dominea C. K. Rathwell Breakdown of academic impact, for papers by Takashi Yoshino Breakdown of academic impact, for papers by Fang Yuan Breakdown of academic impact, for papers by Santosh Keshipeddy Breakdown of academic impact, for papers by Meining Wang
Rankless by CCL
2026